Description
Cell to transfect:
Cell Name: Human Mammary Epithelial Cell (HMEpC, HMEC)
Cell Synonyms: HMEpC, HMEC
Human Mammary Epithelial Cells (HMEpC) are usually derived from normal adult mammary glands. It was shown that normal HMEpC have a high amount of cyclin-dependent kinase 6 activity, which restrains HMEpC proliferation, and loss or down-regulation of cdk 6 may play a role in breast tumor development1. Transforming HMEpC to immortality and malignancy was a useful model for studying early breast carcinogenesis. Autocrine colony-stimulating factor receptors may contribute to invasive progression in epithelial cancer was demonstrated in a 3-dimensional culture of HMEpC.
Applications:
- Breast cancer
- Cellular function and differentiation
- Physiology
- Toxicology
- Hormone regulation
The Transfection Reagent Features:
- Broad spectrum for the transfection of large plasmid, mRNA, siRNA, and/or other type of nucleic acids, which is best for co-transfection of different type and/or size of nucleic acids.
- Specifically optimized to deliver nucleic acids into HMEpC
- Extremely gentle to cells
- 0.5 ml is able to transfect about 1000 wells of 24-well plate
- Deliver single or multiple plasmids
- synthesized from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in research experiments or cells lines
- Compatible with serum
- Suitable for Reverse Transfection
- Reproducible: due to highly controlled chemical synthesis of each of the ingredients, the reagent forms uniformly sized complex particles with nucleic acids. With optimized protocol, our reagent will ensure the reproducible highest transfection results.
- Developed and manufactured by EZ Biosystems
Data
FIG. 1. High throughput test of transfection efficiency (determined as RLU/mg) on human mammary epithelial cell (HMEpC) after transfection of luciferase reporter gene by using our 172 proprietary transfection formulas and several most popular commercial transfection reagents. The yellow box showed the results of 4 commercial transfection reagents. The red lines marked our candidate formulas with the highest transfection efficiency for human mammary epithelial cell (HMEpC). This test result was confirmed with repeat experiments. The one that showed the optimal balance of potent & low cytotoxicity among those candidate formulas after flow cytometry analysis on the percentage of 7AAD positive cells was later named as this Human Mammary Epithelial Cell (HMEpC) Avalanche Transfection Reagent.
For Other Cells
Human Mammary Epithelial Cell (HMEpC, HMEC) Avalanche® Transfection Reagent can also be used on the following cells with high transfection efficiencies.
Human Urethra Epithelial Cell (HUEpC)
Human Renal Epithelial cell (HRE)
Human Cervical Epithelial Cell (HCvEpC)
Human Bladder Epithelial Cell (HBlEpC)
Human Placental Epithelial Cell (HPlEpC)
786-O Cell
Caki-1 Cell
MDCK Cell
Vero Cell
293 Cell
293T/17 Cell
Recommended protocols for these cells will be provided with the reagent. The protocols usually provide satisfactory transfection efficiency with invisible cytotoxicity. However, optimization may be needed for certain type of cells. Optimizations may include: the amount of DNA and this transfection reagent; cell density; transfection reagent/DNA ratio, or incubation time for the mixture of transfection reagent/DNA etc. For best transfection result, we recommend using the respective cell type/cell line specific Avalanche transfection reagents. Those reagents have been optimized on both recipes and protocols, and have been proved to have the best transfection results for the respective cell lines or primary cells. You can easily find the respective Avalanche transfection reagents specific for your cells by using the filters of our product list.
Additional Information
Weight | 0.5 lbs |
---|---|
Adherence Phenotype |
Adherent |
Cell Type |
Epithelial Cell |
Disease |
Healthy |
Names starting from |
H |
Primary/Cell Line |
Primary Cell |
Product Sizes |
0.5 ml, 1.5 ml |
Species |
Human |
Tissue Sources |
Breast/Mammary |
Subcategories |
Cell Type/Cell Line Specific |
Documents
Protocols
MSDS
Citations or Feedback
- Richart, L., Picod-Chedotel, M. L., Wassef, M., Macario, M., Aflaki, S., Salvador, M. A., . . . Ginestier, C. (2022). XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation. Cell. doi:10.1016/j.cell.2022.04.034